MedPath

To study the effect of NIMBAPANCHAKA CHURNA in the management of Purishaja Krimi (Helminthic Infestation )in children.

Phase 3
Not yet recruiting
Conditions
Ascariasis, unspecified. Ayurveda Condition: PURISHAJAKRUMIH,
Registration Number
CTRI/2024/10/076015
Lead Sponsor
Bhagyashree Jagdish Nawlani
Brief Summary

Helminthiasis is the most common paediatric complaint world wide. Most of the world’s population is infected with one of the most common parasites like thread worms, round worms, hook worms, tape worms. The complaints towards the infestation of intestinal worms come with greater incidence in paediatric practice.

Use of uncovered food or improper washing of food materials, poverty, ignorance, lack of hygiene maintenance, bad sanitation etc. are the important factors for spreading helminthic infection in developing countries like India.

Charak, Sushruta, Vagbhata, Madhavnidana, Sharangdhara,Yogratnakar, Bhavprakasha, etc. have given wide description about krimi.

Total 20 krimis are mentioned and are classified as:-

A) Bahya

B) Abhyantara krimi.

Abhyantar krimi further divided into 3 types:-

A) Kaphaja

B) Raktajka

C) Purishaja krimi.

Chikitsa has been evolved in krimiroga in contex viz:-

A) Apakarshana

B) Prakritivighataka

C) Nidan parivarjana.

In Ayurveda many krimighna drugs are mentioned. In this regard ‘Nimbapanchaka Churna’, having krimighna property mentioned in “Yogaratnakara†( shloka -04 in Krimirog chikitsa Adhyaya) is selected.

All that drugs possess properties mentioned for krimighna drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. Patientsirrespective of their gender, religion, & socioeconomic status 2)patients exhibiting symptoms of purishaja krimi mentioned in texts like udarshool, agnimandya, panduta, gudakandu.
Exclusion Criteria
  • 1)Patients below age 3 and above 12 year.
  • 2)Patients presenting with complications occurred due to nematodes infestation 3)Any other systemic diseases which interfere with long term treatment.
  • 4)Patient requiring surgical intervention.
  • 5)Patient with symptoms like Abdominal pain affecting daily activities, Whitish pallor with skin pigmentation, Anal itching with disturbance of activity &sleep.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Udarshool (Abdominal pain)Baseline- 7th, 14th day
Panduta (Pallor)Baseline- 7th, 14th day
Agnimandya(Loss Of Apetite)Baseline- 7th, 14th day
Gudakandu (Anal Itching)Baseline- 7th, 14th day
Secondary Outcome Measures
NameTimeMethod
Panduta (Pallor)Agnimandya(Loss Of Apetite)

Trial Locations

Locations (1)

Chatrapati Shahu Maharaj Shikshan Sansthas Ayurveda Mahavidyalaya and Rugnalaya

🇮🇳

Aurangabad, MAHARASHTRA, India

Chatrapati Shahu Maharaj Shikshan Sansthas Ayurveda Mahavidyalaya and Rugnalaya
🇮🇳Aurangabad, MAHARASHTRA, India
Dr Bhagyashree Jagdish Nawlani
Principal investigator
09175046111
nawlanibhagyashree@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.